121 related articles for article (PubMed ID: 8712691)
1. Evidence for the release of autocrine growth factor(s) by Hodgkin's cell lines.
Imam SA; Taylor CR
Anticancer Res; 1996; 16(4A):1727-32. PubMed ID: 8712691
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a Hodgkin's and B cell-associated glycoprotein.
Wan KR; Wang MJ; Taylor CR; Imam SA
Anticancer Res; 1999; 19(4B):3275-81. PubMed ID: 10652624
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
[TBL] [Abstract][Full Text] [Related]
4. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
Imam A; Stathopoulos E; Taylor CR
Anticancer Res; 1990; 10(4):1095-104. PubMed ID: 1696446
[TBL] [Abstract][Full Text] [Related]
5. Purification and some properties of a lung-derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung.
Cavanaugh PG; Nicolson GL
Cancer Res; 1989 Jul; 49(14):3928-33. PubMed ID: 2544264
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
7. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
Khnykin D; Troen G; Berner JM; Delabie J
J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
[TBL] [Abstract][Full Text] [Related]
8. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
9. Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells.
Lawson DH; Thomas HG; Roy RG; Gordon DS; Chawla RK; Nixon DW; Richmond A
J Cell Biochem; 1987 Jul; 34(3):169-85. PubMed ID: 3611199
[TBL] [Abstract][Full Text] [Related]
10. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice.
McKenna SD; Chen F; Lai L; Goldschneider I
J Immunol; 1998 Mar; 160(5):2272-9. PubMed ID: 9498767
[TBL] [Abstract][Full Text] [Related]
11. Adaptation of human bladder carcinoma cell lines to serum-free growth. Evidence for autocrine growth stimulation.
Ruck A; Jakobson E; Björkman S; Paulie S
Anticancer Res; 1994; 14(1A):55-60. PubMed ID: 8166456
[TBL] [Abstract][Full Text] [Related]
12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
Alas S; Emmanouilides C; Bonavida B
Clin Cancer Res; 2001 Mar; 7(3):709-23. PubMed ID: 11297268
[TBL] [Abstract][Full Text] [Related]
14. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
16. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease.
Wahl AF; Klussman K; Thompson JD; Chen JH; Francisco LV; Risdon G; Chace DF; Siegall CB; Francisco JA
Cancer Res; 2002 Jul; 62(13):3736-42. PubMed ID: 12097283
[TBL] [Abstract][Full Text] [Related]
17. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
18. [Autocrine growth factor produced by a human promyelocytic leukemia cell line].
Kasuga M; Yamanouchi T; Asano T; Tsushima T; Takaku F
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1410-5. PubMed ID: 3460526
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.
Voorzanger N; Touitou R; Garcia E; Delecluse HJ; Rousset F; Joab I; Favrot MC; Blay JY
Cancer Res; 1996 Dec; 56(23):5499-505. PubMed ID: 8968107
[TBL] [Abstract][Full Text] [Related]
20. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
